Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01233_DB08920_nanopub.RAdsb9PX90djvUSmvTxc0C5HUXJTXtIWnIRnCjsy930Qo#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01233_DB08920 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01233_DB08920 label "DDI between Metoclopramide and Zuclopenthixol decanoate - Additive dopamine D2 receptor antagonism may cause dopaminergic imbalance in the nigrostriatal (dopamine D1 receptors) and striatopallidal (dopamine D2 receptors). Increased risk of extrapyramidal reactions and neuroleptic malignant syndrome. Concomitant therapy should be avoided. [drugbank_resource:DB01233_DB08920]" assertion.
- drugbank_resource:DB01233_DB08920 identifier "drugbank_resource:DB01233_DB08920" assertion.
- drugbank_resource:DB01233_DB08920 title "DDI between Metoclopramide and Zuclopenthixol decanoate - Additive dopamine D2 receptor antagonism may cause dopaminergic imbalance in the nigrostriatal (dopamine D1 receptors) and striatopallidal (dopamine D2 receptors). Increased risk of extrapyramidal reactions and neuroleptic malignant syndrome. Concomitant therapy should be avoided." assertion.
- drugbank:DB01233 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01233_DB08920 assertion.
- drugbank:DB08920 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01233_DB08920 assertion.